Drugs Made In America Acquisition (DMII) EBT (2025)

Drugs Made In America Acquisition (DMII) reported EBT of $4.6 million for Q4 2025, up 10041.88% on a QoQ basis from -$46158.0 in Q3 2025.

Drugs Made In America Acquisition (DMII) has 1 years of EBT data on file, last reported at $4.6 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 3.87 Mn
2 Berto Acquisition 316.66 Mn 316.66 Mn - 2.22 Mn
3 Centurion Acquisition 311.94 Mn 311.94 Mn - 2.52 Mn
4 Churchill Capital Corp IX 311.36 Mn 311.36 Mn - 1.49 Mn
5 Agriculture & Natural Solutions Acquisition 301.94 Mn 301.94 Mn - -612,993.00
6 Siddhi Acquisition Corp (Cayman Islands) 286.76 Mn 286.76 Mn - 2.24 Mn
7 Bold Eagle Acquisition 276.06 Mn 276.06 Mn - 2.17 Mn
8 Cartesian Growth Corp III 270.68 Mn 270.68 Mn - 1.68 Mn
9 Oyster Enterprises II Acquisition 266.84 Mn 266.84 Mn - 2.09 Mn
10 Drugs Made In America Acquisition 128.97 Mn 128.97 Mn - 4.59 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 4.59 Mn
Sep 30, 2025 -46,158.00